The endogenous opioid system occupies a pivotal position in the depth-psychology corpus, functioning as the neurobiological substrate through which attachment, social bonding, pleasure, pain relief, and addictive vulnerability are simultaneously explained. The literature does not treat this system as a mere pharmacological curiosity; rather, it serves as the biochemical grammar of some of the most fundamental emotional experiences available to mammals. Panksepp establishes the foundational thesis: brain opioids govern separation distress, and the dynamics of social dependence structurally parallel those of opiate addiction. Maté extends this framework clinically, arguing that early deficits in opioid-mediated bonding create the neurobiological substrate for later chemical dependency. Schore situates the system within the neuroendocrine architecture of attachment imprinting, linking pituitary beta-endorphin production to orbitofrontal maturation. Damasio approaches the system from a homeostatic angle, noting that opioid receptors and their ligands are ancient regulators of well-being whose disruption underlies contemporary crises of addiction and pain. A productive tension runs through the corpus: whether the endogenous opioid system is primarily a system of social reward and bonding, a regulator of physical pain, or the common neurobiological pathway for all hedonic experience. All three positions find serious defenders, and their convergence around the mu-receptor site grants the system unusual explanatory breadth across developmental, clinical, and affective domains.